Gut Microbiota, Inflammation, and Colorectal Cancer

Annual Review of Microbiology

Volumn 70, Issue , 2016, Pages 395-411

  Brennan, Caitlin A ^a   Garrett, Wendy S ^a,b,c,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Colitis; Colorectal cancer; Fusobacterium; Inflammation; Microbiota microbiome; Mucosal immunology

Indexed keywords

ARTICLE; BACTEROIDES FRAGILIS; CANCER GROWTH; COLITIS; COLON CARCINOGENESIS; COLORECTAL CANCER; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; HUMAN; INTESTINE FLORA; METAGENOMICS; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; ANIMAL; COLORECTAL TUMOR; GASTROINTESTINAL TRACT; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY;

ANIMALS; COLORECTAL NEOPLASMS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION;

EID: 84986573153     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-102215-095513     Document Type: Article

References (98)

1. Arpaia N, Campbell C, Fan X,Dikiy S, van der Veeken J, et al. 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504(7480):451-55
2. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, et al. 2012. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120-23
3. Atarashi K, Tanoue T, Ando M, Kamada N, Nagano Y, et al. 2015. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163(2):367-80
4. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331(6015):337-41
5. Ballal SA,Veiga P, Fenn K, MichaudM, Kim JH, et al. 2015. Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons. Proc. Natl. Acad. Sci. USA 112(25):7803-8
6. Beaugerie L, Itzkowitz SH. 2015. Cancers complicating inflammatory bowel disease. N. Engl. J. Med. 372(15):1441-52
7. Beissert S, Bergholz M, Waase I, Lepsien G, Schauer A, et al. 1989. Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization. Proc. Natl. Acad. Sci. USA 86(13):5064-68
8. Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, et al. 2014. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 158(2):288-99
9. Belkaid Y, Hand TW. 2014. Role of the microbiota in immunity and inflammation. Cell 157(1):121-41
10. Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, et al. 2015. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60(2):208-15
11. Boleij A, van Gelder MMHJ, Swinkels DW, Tjalsma H. 2011. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin. Infect. Dis. 53(9):870-78
12. Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, et al. 2010. Phase I study of single-agent antiprogrammed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 28(19):3167-75
13. Burd EM. 2003. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16(1):1-17
14. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, et al. 2012. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6(8):1621-24
15. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, et al. 2012. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22(2):299-306
16. Chun E, Lavoie S, MichaudM, Gallini CA, Kim J, et al. 2015. CCL2 promotes colorectal carcinogenesis by enhancing polymorphonuclear myeloid-derived suppressor cell population and function. Cell Rep. 12(2):244-57
17. ClaessonMJ, Cusack S, O'Sullivan O, Greene-Diniz R, deWeerdH, et al. 2011. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. USA 108(Suppl 1):4586-91
18. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, et al. 2012. Gut microbiota composition correlates with diet and health in the elderly. Nature 488(7410):178-84
19. Coppenhagen-Glazer S, Sol A, Abed J, Naor R, Zhang X, et al. 2015. Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth. Infect. Immun. 83(3):1104-13
20. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede J-P. 2010. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl. Acad. Sci. USA 107(25):11537-42
21. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484):559-63
22. De Simone V, Pallone F, Monteleone G, Stolfi C. 2013. Role of TH17 cytokines in the control of colorectal cancer. Oncoimmunology 2(12):e26617
23. Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, et al. 2014. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl. Acad. Sci. USA 111(51):18321-26
24. Donohoe DR, Holley D, Collins LB, Montgomery SA,Whitmore AC, et al. 2014. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota-and butyrate-dependent manner. Cancer Discov. 4(12):1387-97
25. Dove WF, Clipson L, Gould KA, Luongo C, Marshall DJ, et al. 1997. Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res. 57(5):812-14
26. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107(4):1183-88
27. Elangovan S, Pathania R, Ramachandran S, Ananth S, Padia RN, et al. 2014. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. Cancer Res. 74(4):1166-78
28. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. 2013. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer. 13(11):759-71
29. Feehery GR, Yigit E, Oyola SO, Langhorst BW, Schmidt VT, et al. 2013. A method for selectively enriching microbial DNA from contaminating vertebrate host DNA. PLOS ONE 8(10):e76096
30. Flanagan L, Schmid J, Ebert M, Soucek P, Kunicka T, et al. 2014. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur. J. Clin. Microbiol. Infect. Dis. 33(8):1381-90
31. Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, et al. 2014. Relating the metatranscriptome and metagenome of the human gut. Proc. Natl. Acad. Sci. USA 111(22):E2329-38
32. Fukugaiti MH, Ignacio A, Fernandes MR, Ribeiro Júnior U, Nakano V, Avila-Campos MJ. 2015. High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinalmicrobiota of colorectal carcinoma patients. Braz. J. Microbiol. 46(4):1135-40
33. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, et al. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960-64
34. Garrett WS. 2015. Cancer and the microbiota. Science 348(6230):80-86
35. Geis AL, Fan H, Wu X, Wu S, Huso DL, et al. 2015. Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis. Cancer Discov. 5(10):1098-1109
36. Giannoukos G, Ciulla DM, Huang K, Haas BJ, Izard J, et al. 2012. Efficient and robust RNA-seq process for cultured bacteria and complex community transcriptomes. Genome Biol. 13(3):R23
37. Goldszmid RS, Dzutsev A, Viaud S, Zitvogel L, Restifo NP, Trinchieri G. 2015. Microbiota modulation of myeloid cells in cancer therapy. Cancer Immunol Res. 3(2):103-9
38. Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, et al. 2011. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl. Acad. Sci. USA 108(37):15354-59
39. Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, et al. 2015. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42(2):344-55
40. Han YW, Ikegami A, Rajanna C, Kawsar HI, Zhou Y, et al. 2005. Identification and characterization of a novel adhesin unique to oral fusobacteria. J. Bacteriol. 187(15):5330-40
41. Hoeijmakers JHJ. 2009. DNA damage, aging, and cancer. N. Engl. J. Med. 361(15):1475-85
42. ItoM, Kanno S, Nosho K, Sukawa Y,Mitsuhashi K, et al. 2015. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int. J. Cancer 137(6):1258-68
43. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485-98
44. Johnson CH,Dejea CM, Edler D, Hoang LT, Santidrian AF, et al. 2015. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 21(6):891-97
45. Kaplan CW, Lux R, Haake SK, Shi W. 2009. The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm. Mol. Microbiol. 71(1):35-47
46. Karin M, Greten FR. 2005. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5(10):749-59
47. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. 2004. Diet, nutrition and the prevention of cancer. Public Health Nutr. 7(1A):187-200
48. Kostic AD, Chun E, Robertson L,Glickman JN,Gallini CA, et al. 2013. Fusobacteriumnucleatum inflammation. potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14(2):207-15
49. Kostic AD, Gevers D, Pedamallu CS,Michaud M, Duke F, et al. 2012. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22(2):292-98
50. Kostic AD, Ojesina AI, Pedamallu CS, Jung J, Verhaak RGW, et al. 2011. PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nat. Biotechnol. 29(5):393-96
51. Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, et al. 2015. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372(26):2509-20
52. Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, et al. 2012. Gutmicrobiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 33(6):1231-38
53. Louis P, Hold GL, Flint HJ. 2014. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12(10):661-72
54. Masuda H, Iwai S, Tanaka T, Hayakawa S. 1995. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase. J. Clin. Lab. Immunol. 46(3):111-23
55. McCoy AN, Araújo-Pérez F, Azcárate-Peril A, Yeh JJ, Sandler RS, Keku TO. 2013. Fusobacterium is associated with colorectal adenomas. PLoS ONE 8(1):e53653
56. McIntyre RE, Buczacki SJA, Arends MJ, Adams DJ. 2015. Mousemodels of colorectal cancer as preclinical models. Bioessays 37(8):909-20
57. Melnikov A, Galinsky K, Rogov P, Fennell T, Van Tyne D, et al. 2011. Hybrid selection for sequencing pathogen genomes from clinical samples. Genome Biol. 12(8):R73
58. Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, et al. 2015. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. In press. doi: 10.1136/gutjnl-2015-310101
59. Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, et al. 2015. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 1(5):653-61
60. Moore RA, Warren RL, Freeman JD, Gustavsen JA, Chénard C, et al. 2011. The sensitivity of massively parallel sequencing for detecting candidate infectious agents associated with human tissue. PLoS ONE 6(5):e19838
61. Naik S, Bouladoux N, Linehan JL, Han S-J, Harrison OJ, et al. 2015. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature 520(7545):104-8
62. Naik S, Bouladoux N, Wilhelm C,MolloyMJ, Salcedo R, et al. 2012. Compartmentalized control of skin immunity by resident commensals. Science 337(6098):1115-19
63. Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, et al. 2015. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat. Commun. 6:8727
64. Ng K, Meyerhardt JA, Chan AT, SatoK,Chan JA, et al. 2015. Aspirin andCOX-2 inhibitor use in patients with stage III colon cancer. J. Natl. Cancer Inst. 107(1):345-45
65. Nomura T, Sakaguchi S. 2005. Naturally arising CD25+CD4+ regulatory T cells in tumor immunity. Curr. Top. Microbiol. Immunol. 293:287-302
66. Nougayrede J-P, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, et al. 2006. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313(5788):848-51
67. O'Keefe SJD, Li JV,Lahti L,OuJ, Carbonero F, et al. 2015. Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun. 6:6342
68. O'Keefe SJD, Ou J, Aufreiter S, O'Connor D, Sharma S, et al. 2009. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J. Nutr. 139(11):2044-48
69. Ou J, Carbonero F, Zoetendal EG, DeLany JP, Wang M, et al. 2013. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J. Clin.Nutr. 98(1):111-20
70. Polk DB, Peek RM. 2010. Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer 10(6):403-14
71. RooksMG, Veiga P,Wardwell-Scott LH, Tickle T, Segata N, et al. 2014. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J. 8(7):1403-17
72. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. 2013. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14(2):195-206
73. Schwabe RF, Jobin C. 2013. The microbiome and cancer. Nat. Rev. Cancer 13(11):800-812
74. Sears CL, Garrett WS. 2014. Microbes, microbiota, and colon cancer. Cell Host Microbe. 15(3):317-28
75. Signat B, Roques C, Poulet P, Duffaut D. 2011. Fusobacterium nucleatum in periodontal health and disease. Curr. Issues Mol. Biol. 13(2):25-36
76. SinghN,Gurav A, Sivaprakasam S, BradyE, Padia R, et al. 2014. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40(1):128-39
77. Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, et al. 2015. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350(6264):1084-89
78. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, et al. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341(6145):569-73
79. Song X, Gao H, Lin Y, Yao Y, Zhu S, et al. 2014. Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis. Immunity 40(1):140-52
80. Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, et al. 2011. Invasive potential of gut mucosaderived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 17(9):1971-78
81. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, et al. 1992. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256(5057):668-70
82. Tahara T, Yamamoto E, Suzuki H, Maruyama R, ChungW, et al. 2014. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74(5):1311-18
83. Topalian SL, Drake CG, Pardoll DM. 2015. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27(4):450-61
84. Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, et al. 2006. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 12(8):782-86
85. Uronis JM, Mühlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. 2009. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE. 4(6):e6026
86. Vannucci L, Stepankova R, Kozakova H, Fiserova A, Rossmann P, Tlaskalova-Hogenova H. 2008. Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity. Int. J. Oncol. 32(3):609-17
87. Veiga P, Gallini CA, Beal C, MichaudM, Delaney ML, et al. 2010. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc. Natl. Acad. Sci. USA 107(42):18132-37
88. VétizouM, Pitt JM, Daill ere R, Lepage P,Waldschmitt N, et al. 2015. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350(6264):1079-84
89. Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM. 2015. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS ONE. 10(3):e0119462
90. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, et al. 2011. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 5(2):220-30
91. Wang D, Dubois RN. 2010. The role ofCOX-2 in intestinal inflammation and colorectal cancer. Oncogene 29(6):781-88
92. Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, Huycke MM. 2008. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res. 68(23):9909-17
93. Wang X, Yang Y, Moore DR, Nimmo SL, Lightfoot SA, Huycke MM. 2012. 4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. Gastroenterology 142(3):543-47
94. Warren RL, Freeman DJ, Pleasance S, Watson P, Moore RA, et al. 2013. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 1(1):16
95. Weber G, Shendure J, Tanenbaum DM, Church GM, MeyersonM. 2002. Identification of foreign gene sequences by transcript filtering against the human genome. Nat. Genet. 30(2):141-42
96. Wu S, Rhee K-J, Albesiano E, Rabizadeh S, Wu X, et al. 2009. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15(9):1016-22
97. Yasuda K, Oh K, Ren B, Tickle TL, Franzosa EA, et al. 2015. Biogeography of the intestinal mucosal and lumenal microbiome in the rhesus macaque. Cell Host Microbe 17(3):385-91
98. Zackular JP, Rogers MA, Ruffin MT 4th, Schloss PD. 2014. The human gut microbiome as a screening tool for colorectal caner. Cancer Prev. Res. 7(11):1112-21